Helen M Sammons1, Maria Atkinson, Imti Choonara, Terence Stephenson. 1. Academic Division of Child Health, University of Nottingham, The Medical School, Derbyshire Children's Hospital, Uttoxeter Road Derby, DE22 3DT, UK. helen.sammons@nottingham.ac.uk
Abstract
BACKGROUND: Informed consent is the backbone of a clinical trial. In children this is given by their parents. There have been many studies in the neonatal population but little is known about the views of the parents of infants and young children from within the United Kingdom. The objectives of this study were to assess what motivates parents to consent to a randomised clinical trial (RCT), their feelings on consent and participation and the factors that would influence their decision to take part in a future study. METHODS: The setting was a multi-centre randomised but non-blinded equivalence trial of oral versus intravenous (IV) treatment for community acquired pneumonia in previously well children aged 6 months to 16 years in the UK (PIVOT Study). Parents were sent a postal questionnaire at the end of the study which included open and closed-ended questions. Fishers Exact Test was used to analyse associations in non parametric categorical data. RESULTS:243 children were recruited into the PIVOT study. Of a possible 235, 136 questionnaires were returned (response rate 59%). Of those questionnaires returned; 98% of parents remembered consenting, 95% felt they were given enough time to make their decision and 96% felt they received enough information. Major reasons for participation were benefit to other children in the future 31%, contribution to science 27%, benefit to their own child 18%. Most parents (85%) did not feel obliged to participate. 62% felt there was an advantage to taking part and 18% felt there was a disadvantage. 91% of parents said they would take part in a similar study in the future, stating influences on their decision being benefit to their own child (91%) and benefit to all children (89%). CONCLUSION: The major motivation in parents consenting for their previously well child to participate in an RCT of therapy for an acute medical illness was to increase medical knowledge in the future. Most saw an advantage in taking part in the trial and did not feel obliged to participate.
RCT Entities:
BACKGROUND: Informed consent is the backbone of a clinical trial. In children this is given by their parents. There have been many studies in the neonatal population but little is known about the views of the parents of infants and young children from within the United Kingdom. The objectives of this study were to assess what motivates parents to consent to a randomised clinical trial (RCT), their feelings on consent and participation and the factors that would influence their decision to take part in a future study. METHODS: The setting was a multi-centre randomised but non-blinded equivalence trial of oral versus intravenous (IV) treatment for community acquired pneumonia in previously well children aged 6 months to 16 years in the UK (PIVOT Study). Parents were sent a postal questionnaire at the end of the study which included open and closed-ended questions. Fishers Exact Test was used to analyse associations in non parametric categorical data. RESULTS: 243 children were recruited into the PIVOT study. Of a possible 235, 136 questionnaires were returned (response rate 59%). Of those questionnaires returned; 98% of parents remembered consenting, 95% felt they were given enough time to make their decision and 96% felt they received enough information. Major reasons for participation were benefit to other children in the future 31%, contribution to science 27%, benefit to their own child 18%. Most parents (85%) did not feel obliged to participate. 62% felt there was an advantage to taking part and 18% felt there was a disadvantage. 91% of parents said they would take part in a similar study in the future, stating influences on their decision being benefit to their own child (91%) and benefit to all children (89%). CONCLUSION: The major motivation in parents consenting for their previously well child to participate in an RCT of therapy for an acute medical illness was to increase medical knowledge in the future. Most saw an advantage in taking part in the trial and did not feel obliged to participate.
Authors: M van Stuijvenberg; M H Suur; S de Vos; G C Tjiang; E W Steyerberg; G Derksen-Lubsen; H A Moll Journal: Arch Dis Child Date: 1998-08 Impact factor: 3.791
Authors: Sangeeta Mehta; Friederike Quittnat Pelletier; Maedean Brown; Cheryl Ethier; David Wells; Lisa Burry; Rod MacDonald Journal: Intensive Care Med Date: 2011-11-26 Impact factor: 17.440
Authors: Ran D Goldman; Georg Staubli; Cristina Parra Cotanda; Julie C Brown; Julia Hoeffe; Michelle Seiler; Renana Gelernter; Jeanine E Hall; Mark A Griffiths; Adrienne L Davis; Sergio Manzano; Ahmed Mater; Sara Ahmed; David Sheridan; Matt Hansen; Samina Ali; Graham C Thompson; Naoki Shimizu; Eileen J Klein Journal: Hum Vaccin Immunother Date: 2020-11-23 Impact factor: 3.452
Authors: Alejandro Hoberman; Nader Shaikh; Sonika Bhatnagar; Mary Ann Haralam; Diana H Kearney; D Kathleen Colborn; Michelle L Kienholz; Li Wang; Clareann H Bunker; Ron Keren; Myra A Carpenter; Saul P Greenfield; Hans G Pohl; Ranjiv Mathews; Marva Moxey-Mims; Russell W Chesney Journal: JAMA Pediatr Date: 2013-06 Impact factor: 16.193
Authors: Margaret E Gruen; Katrina N Jiamachello; Andrea Thomson; B Duncan X Lascelles Journal: J Feline Med Surg Date: 2014-06-17 Impact factor: 2.015
Authors: Chyrise B Bradley; Amanda L Tapia; Carolyn G DiGuiseppi; Marti W Kepner; Joy M Kloetzer; Laura A Schieve; Lisa D Wiggins; Gayle C Windham; Julie L Daniels Journal: Paediatr Perinat Epidemiol Date: 2022-02-02 Impact factor: 3.103